Paperpal Prime Logo

Cancer Medicine : Impact Factor & More

eISSN: 2045-7634pISSN: 2045-7634
JournalOpen Access

Key Metrics

CiteScore
6.7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q3Oncology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Medicine

Cancer Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2300 | GBP 1950 | USD 3025
Publication Time19
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Cancer Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Medicine

Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen-Receptor Positive and Triple-Negative Breast Cancer Cell Lines.
  • 1 Jul 2026
  • Cancer medicine
A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor-Associated Immune Cell Infiltration Abundance.
  • 1 Jul 2026
  • Cancer medicine
Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.
  • 1 Jul 2026
  • Cancer medicine
Factors Associated With Optimal Patient-Clinician Communication Among Cancer Survivors.
  • 1 Jul 2026
  • Cancer medicine
Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma.
  • 1 Jul 2026
  • Cancer medicine
Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor.
  • 1 Jul 2026
  • Cancer medicine
Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen-Receptor Positive and Triple-Negative Breast Cancer Cell Lines.
  • 1 Jul 2026
  • Cancer medicine
A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor-Associated Immune Cell Infiltration Abundance.
  • 1 Jul 2026
  • Cancer medicine
Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.
  • 1 Jul 2026
  • Cancer medicine
Factors Associated With Optimal Patient-Clinician Communication Among Cancer Survivors.
  • 1 Jul 2026
  • Cancer medicine
Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma.
  • 1 Jul 2026
  • Cancer medicine
Targeting Temozolomide-Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor.
  • 1 Jul 2026
  • Cancer medicine

FAQs on Cancer Medicine